Indo US Bio-Tech (INDOUS) | Stock Overview & Key Data
Indo US Bio-Tech Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹388.40 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Indo US Bio-Tech
INDOUS
|
2.11B Small-cap | -6.24% | -14.44% | -8.01% | -28.69% | -25.29% | -43.74% | -69.52% | -69.52% | -69.52% | -69.52% | -69.52% |
|
UPL
UPLPP
|
620.31B Large-cap | 0.00% | 0.00% | 16.46% | 24.26% | 24.26% | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% |
|
Coromandel
COROMANDEL
|
588.05B Large-cap | 13.43% | 6.46% | 1.40% | -14.48% | -12.23% | -16.35% | 104.66% | 118.48% | 711.13% | 471.21% | 7,138.29% |
|
Kaveri Seed Company
KSCL
|
48.33B Small-cap | 4.12% | -4.14% | 8.67% | -9.80% | -9.67% | -33.23% | 72.04% | 20.43% | 96.24% | 1,042.55% | 2,016.69% |
|
Dhanuka Agritech
DHANUKA
|
45.54B Small-cap | -0.19% | -0.78% | 9.99% | -10.12% | -8.70% | -35.13% | 36.26% | 11.62% | 68.20% | 1,114.83% | 1,114.83% |
|
Madhya Bharat Agro
MBAPL
|
44.41B Small-cap | 3.75% | 5.86% | 26.12% | 39.98% | 32.38% | 61.61% | 74.48% | 1,952.84% | 7,351.06% | 7,351.06% | 7,351.06% |
Ownership & Short Interest
Calculate Your Indo US Bio-Tech Investment Returns
Long-Term Investment Performance Analysis
Indo US Bio-Tech stock price in Sep 2024 was ₹292.60, A ₹1,000.00 lump sum investment in Indo US Bio-Tech made 1 years ago would be worth approximately ₹307.69 today, representing a negative return of -69.23%. This translates to an annualized return (CAGR) of -49.51%.
1 Year 8 Months Investment Scenario (Sep 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is INDOUS's 52-week high and low?
- In the last 52 weeks, Indo US Bio-Tech reached a high of ₹206.00 (on July 21, 2025) and a low of ₹88.02 (on June 12, 2026).
- What is the market cap and P/E ratio for INDOUS?
- Curious about Indo US Bio-Tech's size and valuation? Its market capitalization stands at 2.11B. When it comes to valuation, the P/E ratio (trailing twelve months) is 14.45, and the forward P/E (looking ahead) is N/A.
- Does INDOUS pay dividends? If so, what's the yield?
- Yes, Indo US Bio-Tech is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.16%, and the company has paid an average of ₹0.08 per share annually over the past 3 years.
- Who are Indo US Bio-Tech's main competitors or similar companies to consider before investing?
When looking at Indo US Bio-Tech, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UPL
UPLPP620.31B Basic Materials Agricultural Inputs 104.96% 104.96% Coromandel
COROMANDEL588.05B Basic Materials Agricultural Inputs -16.35% 104.66% Kaveri Seed Company
KSCL48.33B Basic Materials Agricultural Inputs -33.23% 72.04% Dhanuka Agritech
DHANUKA45.54B Basic Materials Agricultural Inputs -35.13% 36.26% Madhya Bharat Agro
MBAPL44.41B Basic Materials Agricultural Inputs 61.61% 74.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Indo US Bio-Tech Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Indo US Bio-Tech's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.72%, the Debt to Equity ratio from the most recent quarter is 31.90, and its Gross Profit Margin stands at 29.90%.
- What is the recent revenue and earnings growth for INDOUS?
- Looking at Indo US Bio-Tech's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -3.20%, and quarterly earnings saw a YoY growth of -40.70%.
- How much of INDOUS stock is held by insiders and institutions?
- Wondering who owns Indo US Bio-Tech stock? Company insiders (like executives and directors) hold about 75.65% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.